Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans

Leishmaniasis is endemic in at least 98 countries. Due to the high toxicity and resistance associated with the drugs, we chose lignans as an alternative, due to their favorable properties of absorption, distribution, metabolism, excretion, and toxicity (ADMET). To investigate their leishmanicidal po...

Full description

Bibliographic Details
Main Authors: Mayara dos Santos Maia, Joanda Paolla Raimundo e Silva, Thaís Amanda de Lima Nunes, Julyanne Maria Saraiva de Sousa, Gabriela Cristina Soares Rodrigues, Alex France Messias Monteiro, Josean Fechine Tavares, Klinger Antonio da Franca Rodrigues, Francisco Jaime B. Mendonça-Junior, Luciana Scotti, Marcus Tullius Scotti
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/10/2281
_version_ 1797568156893446144
author Mayara dos Santos Maia
Joanda Paolla Raimundo e Silva
Thaís Amanda de Lima Nunes
Julyanne Maria Saraiva de Sousa
Gabriela Cristina Soares Rodrigues
Alex France Messias Monteiro
Josean Fechine Tavares
Klinger Antonio da Franca Rodrigues
Francisco Jaime B. Mendonça-Junior
Luciana Scotti
Marcus Tullius Scotti
author_facet Mayara dos Santos Maia
Joanda Paolla Raimundo e Silva
Thaís Amanda de Lima Nunes
Julyanne Maria Saraiva de Sousa
Gabriela Cristina Soares Rodrigues
Alex France Messias Monteiro
Josean Fechine Tavares
Klinger Antonio da Franca Rodrigues
Francisco Jaime B. Mendonça-Junior
Luciana Scotti
Marcus Tullius Scotti
author_sort Mayara dos Santos Maia
collection DOAJ
description Leishmaniasis is endemic in at least 98 countries. Due to the high toxicity and resistance associated with the drugs, we chose lignans as an alternative, due to their favorable properties of absorption, distribution, metabolism, excretion, and toxicity (ADMET). To investigate their leishmanicidal potential, the biological activities of a set of 160 lignans were predicted using predictive models that were built using data for <i>Leishmania</i> <i>major</i> and <i>L. (Viannia) braziliensis</i>. A combined analysis, based on ligand and structure, and several other computational approaches were used. The results showed that the combined analysis was able to select 11 lignans with potential activity against <i>L. major</i> and 21 lignans against <i>L. braziliensis</i>, with multitargeting effects and low or no toxicity. Of these compounds, four were isolated from the species <i>Justicia</i> <i>aequilabris</i> (Nees) Lindau. All of the identified compounds were able to inhibit the growth of <i>L. braziliensis</i> promastigotes, with the most active compound, (<b>159</b>) epipinoresinol-4-<i>O</i>-β-<span style="font-variant: small-caps;">d</span>-glucopyranoside, presenting an IC<sub>50</sub> value of 5.39 µM and IC<sub>50</sub> value of 36.51 µM for <i>L. major</i>. Our findings indicated the potential of computer-aided drug design and development and demonstrated that lignans represent promising prototype compounds for the development of multitarget drugs against leishmaniasis.
first_indexed 2024-03-10T19:52:28Z
format Article
id doaj.art-50b47054f12c41a9b2eda1a0d5745f85
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T19:52:28Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-50b47054f12c41a9b2eda1a0d5745f852023-11-20T00:13:27ZengMDPI AGMolecules1420-30492020-05-012510228110.3390/molecules25102281Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of LignansMayara dos Santos Maia0Joanda Paolla Raimundo e Silva1Thaís Amanda de Lima Nunes2Julyanne Maria Saraiva de Sousa3Gabriela Cristina Soares Rodrigues4Alex France Messias Monteiro5Josean Fechine Tavares6Klinger Antonio da Franca Rodrigues7Francisco Jaime B. Mendonça-Junior8Luciana Scotti9Marcus Tullius Scotti10Laboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, BrazilMulti-User Characterization and Analysis Laboratory, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, BrazilInfectious Diseases Laboratory, Federal University of Parnaíba Delta, São Benedito, Parnaíba-PI 64202-020, BrazilInfectious Diseases Laboratory, Federal University of Parnaíba Delta, São Benedito, Parnaíba-PI 64202-020, BrazilLaboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, BrazilLaboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, BrazilMulti-User Characterization and Analysis Laboratory, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, BrazilInfectious Diseases Laboratory, Federal University of Parnaíba Delta, São Benedito, Parnaíba-PI 64202-020, BrazilLaboratory of Synthesis and Drug Delivery, State University of Paraíba, João Pessoa-PB 58071-160, BrazilLaboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, BrazilLaboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, BrazilLeishmaniasis is endemic in at least 98 countries. Due to the high toxicity and resistance associated with the drugs, we chose lignans as an alternative, due to their favorable properties of absorption, distribution, metabolism, excretion, and toxicity (ADMET). To investigate their leishmanicidal potential, the biological activities of a set of 160 lignans were predicted using predictive models that were built using data for <i>Leishmania</i> <i>major</i> and <i>L. (Viannia) braziliensis</i>. A combined analysis, based on ligand and structure, and several other computational approaches were used. The results showed that the combined analysis was able to select 11 lignans with potential activity against <i>L. major</i> and 21 lignans against <i>L. braziliensis</i>, with multitargeting effects and low or no toxicity. Of these compounds, four were isolated from the species <i>Justicia</i> <i>aequilabris</i> (Nees) Lindau. All of the identified compounds were able to inhibit the growth of <i>L. braziliensis</i> promastigotes, with the most active compound, (<b>159</b>) epipinoresinol-4-<i>O</i>-β-<span style="font-variant: small-caps;">d</span>-glucopyranoside, presenting an IC<sub>50</sub> value of 5.39 µM and IC<sub>50</sub> value of 36.51 µM for <i>L. major</i>. Our findings indicated the potential of computer-aided drug design and development and demonstrated that lignans represent promising prototype compounds for the development of multitarget drugs against leishmaniasis.https://www.mdpi.com/1420-3049/25/10/2281leishmaniasislignanvirtual screeningmolecular dockingcomputer-aided drug design
spellingShingle Mayara dos Santos Maia
Joanda Paolla Raimundo e Silva
Thaís Amanda de Lima Nunes
Julyanne Maria Saraiva de Sousa
Gabriela Cristina Soares Rodrigues
Alex France Messias Monteiro
Josean Fechine Tavares
Klinger Antonio da Franca Rodrigues
Francisco Jaime B. Mendonça-Junior
Luciana Scotti
Marcus Tullius Scotti
Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans
Molecules
leishmaniasis
lignan
virtual screening
molecular docking
computer-aided drug design
title Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans
title_full Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans
title_fullStr Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans
title_full_unstemmed Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans
title_short Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans
title_sort virtual screening and the in vitro assessment of the antileishmanial activity of lignans
topic leishmaniasis
lignan
virtual screening
molecular docking
computer-aided drug design
url https://www.mdpi.com/1420-3049/25/10/2281
work_keys_str_mv AT mayaradossantosmaia virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT joandapaollaraimundoesilva virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT thaisamandadelimanunes virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT julyannemariasaraivadesousa virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT gabrielacristinasoaresrodrigues virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT alexfrancemessiasmonteiro virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT joseanfechinetavares virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT klingerantoniodafrancarodrigues virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT franciscojaimebmendoncajunior virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT lucianascotti virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans
AT marcustulliusscotti virtualscreeningandtheinvitroassessmentoftheantileishmanialactivityoflignans